Clinical trial
Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria
NCT00158561 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00158561 |
|---|---|
| Title | Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria |
| Official title | An Open-label Three Arm Trial of the Efficacy and Safety of Chlorproguanil / Dapsone (Lapdap) Compared With Chloroquine and Sulfadoxine / Pyrimethamine for the Treatment of Vivax Malaria in Pakistan and Afghanistan |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | HealthNet TPO |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria, Vivax Malaria |
| Intervention type | Drug |
| Interventions | sulfadoxine-pyrimethamine and chlorproguanil-dapsone |
| Enrollment | 750 |
| Start date | Feb 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | Pakistan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: